{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30158996", "DateRevised": {"Year": "2020", "Month": "09", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "08", "Day": "07"}], "Language": ["eng"], "ELocationID": ["5921514", "10.1155/2018/5921514"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2018", "PubDate": {"Year": "2018"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Pharmacological Evaluation of <i>Mentha spicata</i> L. and <i>Plantago major</i> L., Medicinal Plants Used to Treat Anxiety and Insomnia in Colombian Caribbean Coast.", "Pagination": {"StartPage": "5921514", "MedlinePgn": "5921514"}, "Abstract": {"AbstractText": ["Anxiety disorders are highly prevalent, chronic, and disabling conditions that impose enormous health and economic costs both on individuals and on society. Medicinal plants are an invaluable source of bioactive metabolites that can be useful as new pharmacological treatment. Teas from <i>Mentha spicata</i> and <i>Plantago major</i> are employed by Colombian populations to treat stress and insomnia. This work was conducted to evaluate their anxiolytic and hypnotic properties. For this, we employed the Elevated Plus-Maze test and the sodium pentobarbital-induced hypnosis method using Wistar rats. Oral administration of <i>M. spicata</i> extract (1000 mg/Kg) significantly increased the exploration and time spent in the open arms, which indicates its anxiolytic activity. On the other hand, both <i>M. spicata</i> and <i>P. major</i> extracts (1000 mg/Kg) remarkably augmented the sleeping time induced by pentobarbital, suggesting a sedative and hypnotic effect of the plants extracts. In addition, the acute toxicological study demonstrated that the doses used did not induce mortality or toxicity effects at hepatic or renal level. The bioactivity seems to be related to several kinds of constituents, mainly phenolic compounds such as flavonoids and tannins. In conclusion, these results reinforce the potential use of these species in the therapy of anxiety."]}, "AuthorList": [{"Identifier": ["0000-0001-8079-5664"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biological Evaluation of Promising Substances Group, Faculty of Pharmaceutical Sciences, University of Cartagena, Cartagena 130015, Colombia."}], "LastName": "Caro", "ForeName": "Daneiva C", "Initials": "DC"}, {"Identifier": ["0000-0002-0132-0335"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biological Evaluation of Promising Substances Group, Faculty of Pharmaceutical Sciences, University of Cartagena, Cartagena 130015, Colombia."}], "LastName": "Rivera", "ForeName": "David E", "Initials": "DE"}, {"Identifier": ["0000-0003-2001-3848"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biological Evaluation of Promising Substances Group, Faculty of Pharmaceutical Sciences, University of Cartagena, Cartagena 130015, Colombia."}], "LastName": "Ocampo", "ForeName": "Yanet", "Initials": "Y"}, {"Identifier": ["0000-0003-2983-0836"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biological Evaluation of Promising Substances Group, Faculty of Pharmaceutical Sciences, University of Cartagena, Cartagena 130015, Colombia."}], "LastName": "Franco", "ForeName": "Luis A", "Initials": "LA"}, {"Identifier": ["0000-0003-0583-7304"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biological Evaluation of Promising Substances Group, Faculty of Pharmaceutical Sciences, University of Cartagena, Cartagena 130015, Colombia."}], "LastName": "Salas", "ForeName": "Rub\u00e9n D", "Initials": "RD"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Baxter A. J., Vos T., Scott K. M., Ferrari A. J., Whiteford H. A. The global burden of anxiety disorders in 2010. Psychological Medicine. 2014;44(11):2363\u20132374. doi: 10.1017/S0033291713003243.", "ArticleIdList": ["10.1017/S0033291713003243", "24451993"]}, {"Citation": "Ruscio A. M., Hallion L. S., Lim C. C., et al. Cross-sectional Comparison of the Epidemiology of. JAMA Psychiatry. 2017;74(5):465\u2013475. doi: 10.1001/jamapsychiatry.2017.0056.", "ArticleIdList": ["10.1001/jamapsychiatry.2017.0056", "PMC5594751", "28297020"]}, {"Citation": "American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th. Vol. 1. Arlington, Va, USA: American Psychiatric Association; 2013.", "ArticleIdList": ["10.1176/appi.books.9780890423349"]}, {"Citation": "Cuijpers P., Sijbrandij M., Koole S., Huibers M., Berking M., Andersson G. Psychological treatment of generalized anxiety disorder: A meta-analysis. Clinical Psychology Review. 2014;34(2):130\u2013140. doi: 10.1016/j.cpr.2014.01.002.", "ArticleIdList": ["10.1016/j.cpr.2014.01.002", "24487344"]}, {"Citation": "Generoso M. B., Trevizol A. P., Kasper S., Cho H. J., Cordeiro Q., Shiozawa P. Pregabalin for generalized anxiety disorder: An updated systematic review and meta-analysis. International Clinical Psychopharmacology. 2017;32(1):49\u201355. doi: 10.1097/YIC.0000000000000147.", "ArticleIdList": ["10.1097/YIC.0000000000000147", "27643884"]}, {"Citation": "Chisholm D., Sweeny K., Sheehan P., et al. Scaling-up treatment of depression and anxiety: A global return on investment analysis. The Lancet Psychiatry. 2016;3(5):415\u2013424. doi: 10.1016/S2215-0366(16)30024-4.", "ArticleIdList": ["10.1016/S2215-0366(16)30024-4", "27083119"]}, {"Citation": "MINSALUD. \u201cEncuesta Nacional de Salud Mental 2015\u201d, ed. Javegraf, Bogota, Colombia, 2016."}, {"Citation": "Posada-Villa MD, Buitrago-Bonilla TS, Medina-Barreto TS, Rodr\u00edguez-Ospina. MD M. Trastornos de ansiedad seg\u00fan distribuci\u00f3n por edad, g\u00e9nero, variaciones por regiones, edad de aparici\u00f3n, uso de servicios, estado civil y funcionamiento/discapacidad seg\u00fan el Estudio Nacional de Salud Mental-Colombia. NOVA. 2006;4(6):33\u201341. doi: 10.22490/24629448.358.", "ArticleIdList": ["10.22490/24629448.358"]}, {"Citation": "Craske M. G., Stein M. B. Anxiety. The Lancet. 2016;388(10063):3048\u20133059. doi: 10.1016/S0140-6736(16)30381-6.", "ArticleIdList": ["10.1016/S0140-6736(16)30381-6", "27349358"]}, {"Citation": "Lader M., Kyriacou A. Withdrawing Benzodiazepines in Patients With Anxiety Disorders. Current Psychiatry Reports. 2016;18(1) doi: 10.1007/s11920-015-0642-5.", "ArticleIdList": ["10.1007/s11920-015-0642-5", "26733324"]}, {"Citation": "Stein M. B., Craske M. G. Treating anxiety in 2017 optimizing care to improve outcomes. Journal of the American Medical Association. 2017;318(3):235\u2013236. doi: 10.1001/jama.2017.6996.", "ArticleIdList": ["10.1001/jama.2017.6996", "28679009"]}, {"Citation": "G\u00f3mez S., Le\u00f3n T., Macuer M., Alves M., Ruiz S. Benzodiazepine use in elderly population in latin America. Revista M\u00e9dica de Chile. 2017;145(3):351\u2013359. doi: 10.4067/S0034-98872017000300009.", "ArticleIdList": ["10.4067/S0034-98872017000300009", "28548192"]}, {"Citation": "Machado-Alba J. E., Alzate-Carvajal V., Jimenez-Canizales C. E. Trends in the consumption of anxiolytic and hypnotic drugs in a Colombian population. Revista Colombiana de Psiquiatria. 2015;44(2):93\u201399. doi: 10.1016/j.rcp.2015.01.007.", "ArticleIdList": ["10.1016/j.rcp.2015.01.007", "26578331"]}, {"Citation": "Voces Garc\u00eda D., D\u00edaz G\u00f3mez Calcerrada C., Puente Garc\u00eda N. Uso de plantas medicinales en el tratamiento de la ansiedad y la depresi\u00f3n. FMC - Formaci\u00f3n M\u00e9dica Continuada en Atenci\u00f3n Primaria. 2002;9(1):50\u201356. doi: 10.1016/S1134-2072(02)75530-8.", "ArticleIdList": ["10.1016/S1134-2072(02)75530-8"]}, {"Citation": "Sarris J., McIntyre E., Camfield D. A. Plant-based medicines for anxiety disorders, part 1: a review of preclinical studies. CNS Drugs. 2013;27(3):207\u2013219. doi: 10.1007/s40263-013-0044-3.", "ArticleIdList": ["10.1007/s40263-013-0044-3", "23436255"]}, {"Citation": "Sarris J., McIntyre E., Camfield D. A. Erratum: Plant-based medicines for anxiety disorders, Part 2: A review of clinical studies with supporting preclinical evidence (CNS Drugs (2013) 27:4 (301-319) DOI:10.1007/s40263-013-0059-9) CNS Drugs. 2013;27(8):p. 675. doi: 10.1007/s40263-013-0087-5.", "ArticleIdList": ["10.1007/s40263-013-0087-5", "23653088"]}, {"Citation": "TRAMIL. Plantas medicinales caribe\u00f1as para la atenci\u00f3n primaria, Manual Pr\u00e1ctico. Guadaloupe, France: PBL Editions; 2008."}, {"Citation": "Herrera Herrera Alejandra, Franco Ospina Luis, Fang Luis, D\u00edaz Caballero Antonio. Susceptibility of Porphyromonas gingivalis and Streptococcus mutans to Antibacterial Effect from Mammea americana. Advances in Pharmacological Sciences. 2014;2014:6. doi: 10.1155/2014/384815.384815", "ArticleIdList": ["10.1155/2014/384815", "PMC4017792", "24864137"]}, {"Citation": "Taiwo A. E., Leite F. B., Lucena G. M., et al. Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: Influence of administration and gender. Indian Journal of Pharmacology. 2012;44(2):189\u2013192. doi: 10.4103/0253-7613.93846.", "ArticleIdList": ["10.4103/0253-7613.93846", "PMC3326910", "22529473"]}, {"Citation": "CYTED. Manual de T\u00e9cnicas de Investigaci\u00f3n, Subprograma X. Qu\u00edmica Fina Farmac\u00e9utica. Proyecto X-1. B\u00fasqueda de Principios Bioactivos en Plantas de la Regi\u00f3n. 1995."}, {"Citation": "Vergel N. Biblioteca virtual para la vigilancia en salud p\u00fablica de Colombia. Colombia: Universidad Nacional de Colombia, Departamento de Farmacia; 2011. Estudio de la actividad anticonvulsivante de metabolitos secundarios tipo cumarina [Tesis de Doctorado]15485"}, {"Citation": "Pellow S., Chopin P., File S. E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods. 1985;14(3):149\u2013167. doi: 10.1016/0165-0270(85)90031-7.", "ArticleIdList": ["10.1016/0165-0270(85)90031-7", "2864480"]}, {"Citation": "Pellow S., File S. E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat. Pharmacology Biochemistry & Behavior. 1986;24(3):525\u2013529. doi: 10.1016/0091-3057(86)90552-6.", "ArticleIdList": ["10.1016/0091-3057(86)90552-6", "2871560"]}, {"Citation": "Walf A. A., Frye C. A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nature Protocols. 2007;2(2):322\u2013328. doi: 10.1038/nprot.2007.44.", "ArticleIdList": ["10.1038/nprot.2007.44", "PMC3623971", "17406592"]}, {"Citation": "Sugden D. Psychopharmacological effects of melatonin in mouse and rat. The Journal of Pharmacology and Experimental Therapeutics. 1983;227(3):587\u2013591.", "ArticleIdList": ["6655558"]}, {"Citation": "Correa I. D., Alcantara-Carrio J., Gonzalez D. A. Historical and Recent Shore Erosion along the Colombian Caribbean Coast , Journal of Coastal Research. special. 2005;no. 49:52\u201357."}, {"Citation": "Blumenthal M., Cavaliere C., Rea P., Lynch M. Growth and market trends for herbal products in the United States. Planta Medica. 2010;76(12) doi: 10.1055/s-0030-1264554.", "ArticleIdList": ["10.1055/s-0030-1264554"]}, {"Citation": "Naghibi F., Mosaddegh M., Mohammadi Motamed M., Ghorbani A. Labiatae Family in folk Medicine in Iran: from Ethnobotany to Pharmacology. Iranian Journal of Pharmaceutical Research. 2005;4(2):63\u201379."}, {"Citation": "Chandra S., Rawat D., Chandra D., Rastogi J. Nativity, Phytochemistry, Ethnobotany and Pharmacology of Dianthus caryophyllus. Research Journal of Medicinal Plant. 2016;10(1):1\u20139. doi: 10.3923/rjmp.2016.1.9.", "ArticleIdList": ["10.3923/rjmp.2016.1.9"]}, {"Citation": "Yeung W.-F., Chung K.-F., Man-Ki Poon M., et al. Chinese herbal medicine for insomnia: a systematic review of randomized controlled trials. Sleep Medicine Reviews. 2012;16(6):497\u2013507. doi: 10.1016/j.smrv.2011.12.005.", "ArticleIdList": ["10.1016/j.smrv.2011.12.005", "22440393"]}, {"Citation": "Loera J. A., Black S. A., Markides K. S., Espino D. V., Goodwin J. S. The use of herbal medicine by older Mexican Americans. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2001;56(11):M714\u2013M718. doi: 10.1093/gerona/56.11.M714.", "ArticleIdList": ["10.1093/gerona/56.11.M714", "11682580"]}, {"Citation": "Ahmed H. M. Ethnopharmacobotanical study on the medicinal plants used by herbalists in Sulaymaniyah Province, Kurdistan, Iraq. Journal of Ethnobiology and Ethnomedicine. 2016;12(1, article no. 8) doi: 10.1186/s13002-016-0081-3.", "ArticleIdList": ["10.1186/s13002-016-0081-3", "PMC4730727", "26821541"]}, {"Citation": "Fonnegra G. R., Jimenez R. S. 2. 2nd. Medellin, Colombia: Universidad de Antioquia, Colecci\u00f3n Salud/Inter\u00e9s General; 2007. Plantas medicinales aprobadas en Colombia."}, {"Citation": "K\u00fclt\u00fcr \u015e. Medicinal plants used in K\u0131rklareli Province (Turkey) Journal of Ethnopharmacology. 2007;111(2):341\u2013364. doi: 10.1016/j.jep.2006.11.035.", "ArticleIdList": ["10.1016/j.jep.2006.11.035", "17257791"]}, {"Citation": "Neves J. M., Matos C., Moutinho C., Queiroz G., Gomes L. R. Ethnopharmacological notes about ancient uses of medicinal plants in Tr\u00e1s-os-Montes (northern of Portugal) Journal of Ethnopharmacology. 2009;124(2):270\u2013283. doi: 10.1016/j.jep.2009.04.041.", "ArticleIdList": ["10.1016/j.jep.2009.04.041", "19409473"]}, {"Citation": "Capasso R., Izzo A. A., Pinto L., Bifulco T., Vitobello C., Mascolo N. Phytotherapy and quality of herbal medicines. Fitoterapia. 2000;71(supplement 1):S58\u2013S65. doi: 10.1016/s0367-326x(00)00173-8.", "ArticleIdList": ["10.1016/s0367-326x(00)00173-8", "10930714"]}, {"Citation": "Akdogan M., Kwiwnc I., Oncu M., Karaoz E., Delibas N. Investigation of biochemical and histopathological effects of Mentha piperita L. and Mentha spicata L. on kidney tissue in rats. Human & Experimental Toxicology. 2003;22(4):213\u2013219. doi: 10.1191/0960327103ht332oa.", "ArticleIdList": ["10.1191/0960327103ht332oa", "12755472"]}, {"Citation": "Akdogan M., Ozguner M., Aydin G., Gokalp O. Investigation of biochemical and histopathological effects of Mentha piperita Labiatae and Mentha spicata Labiatae on liver tissue in rats. Human & Experimental Toxicology. 2004;23(1):21\u201328. doi: 10.1191/0960327104ht412oa.", "ArticleIdList": ["10.1191/0960327104ht412oa", "15027812"]}, {"Citation": "Akdogan M., Ozguner M., Kocak A., Oncu M., Cicek E. Effects of peppermint teas on plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels and testicular tissue in rats. Urology. 2004;64(2):394\u2013398. doi: 10.1016/j.urology.2004.03.046.", "ArticleIdList": ["10.1016/j.urology.2004.03.046", "15302514"]}, {"Citation": "Cruz A. P. M., Frei F., Graeff F. G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacology Biochemistry & Behavior. 1994;49(1):171\u2013176. doi: 10.1016/0091-3057(94)90472-3.", "ArticleIdList": ["10.1016/0091-3057(94)90472-3", "7816869"]}, {"Citation": "Espejo E. F. Structure of the mouse behaviour on the elevated plus-maze test of anxiety. Behavioural Brain Research. 1997;86(1):105\u2013112. doi: 10.1016/S0166-4328(96)02245-0.", "ArticleIdList": ["10.1016/S0166-4328(96)02245-0", "9105588"]}, {"Citation": "Griebel G., Holmes A. 50 years of hurdles and hope in anxiolytic drug discovery. Nature Reviews Drug Discovery. 2013;12(9):667\u2013687. doi: 10.1038/nrd4075.", "ArticleIdList": ["10.1038/nrd4075", "PMC4176700", "23989795"]}, {"Citation": "Paladini A. C., Marder M., Viola H., Wolfman C., Wasowski C., Medina J. H. Flavonoids and the central nervous system: From forgotten factors to potent anxiolytic compounds. Journal of Pharmacy and Pharmacology. 1999;51(5):519\u2013526. doi: 10.1211/0022357991772790.", "ArticleIdList": ["10.1211/0022357991772790", "10411210"]}, {"Citation": "Hanrahan J. R., Chebib M., Johnston G. A. R. Flavonoid modulation of GABAA receptors. British Journal of Pharmacology. 2011;163(2):234\u2013245. doi: 10.1111/j.1476-5381.2011.01228.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01228.x", "PMC3087128", "21244373"]}, {"Citation": "Hanrahan J. R., Chebib M., Johnston G. A. R. Interactions of flavonoids with ionotropic GABA receptors. Advances in Pharmacology. 2015;72:189\u2013200. doi: 10.1016/bs.apha.2014.10.007.", "ArticleIdList": ["10.1016/bs.apha.2014.10.007", "25600371"]}]}], "History": [{"Year": "2018", "Month": "2", "Day": "27"}, {"Year": "2018", "Month": "5", "Day": "17"}, {"Year": "2018", "Month": "6", "Day": "11"}, {"Year": "2018", "Month": "8", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "31", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "8", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["30158996", "PMC6106973", "10.1155/2018/5921514"]}}]}